These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38285062)

  • 1. Engineering poly(ethylene glycol) particles for targeted drug delivery.
    Li S; Ma Y; Cui J; Caruso F; Ju Y
    Chem Commun (Camb); 2024 Feb; 60(19):2591-2604. PubMed ID: 38285062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoengineering of Poly(ethylene glycol) Particles for Stealth and Targeting.
    Cui J; Björnmalm M; Ju Y; Caruso F
    Langmuir; 2018 Sep; 34(37):10817-10827. PubMed ID: 30132674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating Targeting of Poly(ethylene glycol) Particles to Tumor Cells Using Bispecific Antibodies.
    Cui J; Ju Y; Houston ZH; Glass JJ; Fletcher NL; Alcantara S; Dai Q; Howard CB; Mahler SM; Wheatley AK; De Rose R; Brannon PT; Paterson BM; Donnelly PS; Thurecht KJ; Caruso F; Kent SJ
    Adv Healthc Mater; 2019 May; 8(9):e1801607. PubMed ID: 30868751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-Functionalized Poly(ethylene glycol) Particles for Tumor Targeting and Intracellular Uptake.
    Cui J; Alt K; Ju Y; Gunawan ST; Braunger JA; Wang TY; Dai Y; Dai Q; Richardson JJ; Guo J; Björnmalm M; Hagemeyer CE; Caruso F
    Biomacromolecules; 2019 Sep; 20(9):3592-3600. PubMed ID: 31448896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering Well-Characterized PEG-Coated Nanoparticles for Elucidating Biological Barriers to Drug Delivery.
    Yang Q; Lai SK
    Methods Mol Biol; 2017; 1530():125-137. PubMed ID: 28150200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary study on MeO-PEG-PLGA-PEG-OMe nanoparticles as intravenous carriers.
    Duan Y; Xu J; Lin Y; Yu H; Gong T; Li Y; Zhang Z
    J Biomed Mater Res A; 2008 Nov; 87(2):515-23. PubMed ID: 18186066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering poly(ethylene glycol) particles for improved biodistribution.
    Cui J; De Rose R; Alt K; Alcantara S; Paterson BM; Liang K; Hu M; Richardson JJ; Yan Y; Jeffery CM; Price RI; Peter K; Hagemeyer CE; Donnelly PS; Kent SJ; Caruso F
    ACS Nano; 2015 Feb; 9(2):1571-80. PubMed ID: 25712853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed micelles of lipoic acid-chitosan-poly(ethylene glycol) and distearoylphosphatidylethanolamine-poly(ethylene glycol) for tumor delivery.
    Elsaid Z; Taylor KM; Puri S; Eberlein CA; Al-Jamal K; Bai J; Klippstein R; Wang JT; Forbes B; Chana J; Somavarapu S
    Eur J Pharm Sci; 2017 Apr; 101():228-242. PubMed ID: 28163163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To PEGylate or not to PEGylate: Immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives.
    Shi D; Beasock D; Fessler A; Szebeni J; Ljubimova JY; Afonin KA; Dobrovolskaia MA
    Adv Drug Deliv Rev; 2022 Jan; 180():114079. PubMed ID: 34902516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of star poly(ethylene glycol) derivatives in drug delivery and controlled release.
    Zhao X; Si J; Huang D; Li K; Xin Y; Sui M
    J Control Release; 2020 Jul; 323():565-577. PubMed ID: 32343992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinspired "Active" Stealth Magneto-Nanomicelles for Theranostics Combining Efficient MRI and Enhanced Drug Delivery.
    Zhang KL; Zhou J; Zhou H; Wu Y; Liu R; Wang LL; Lin WW; Huang G; Yang HH
    ACS Appl Mater Interfaces; 2017 Sep; 9(36):30502-30509. PubMed ID: 28812358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo Studies on Pharmacokinetics, Toxicity and Immunogenicity of Polyelectrolyte Nanocapsules Functionalized with Two Different Polymers: Poly-L-Glutamic Acid or PEG.
    Karabasz A; Szczepanowicz K; Cierniak A; Mezyk-Kopec R; Dyduch G; Szczęch M; Bereta J; Bzowska M
    Int J Nanomedicine; 2019; 14():9587-9602. PubMed ID: 31824153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives.
    Knop K; Hoogenboom R; Fischer D; Schubert US
    Angew Chem Int Ed Engl; 2010 Aug; 49(36):6288-308. PubMed ID: 20648499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of poly(ethylene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery.
    Wang R; Xiao R; Zeng Z; Xu L; Wang J
    Int J Nanomedicine; 2012; 7():4185-98. PubMed ID: 22904628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body distribution and in situ evading of phagocytic uptake by macrophages of long-circulating poly (ethylene glycol) cyanoacrylate-co-n-hexadecyl cyanoacrylate nanoparticles.
    Huang M; Wu W; Qian J; Wan DJ; Wei XL; Zhu JH
    Acta Pharmacol Sin; 2005 Dec; 26(12):1512-8. PubMed ID: 16297352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DSPE-PEG: a distinctive component in drug delivery system.
    Che J; Okeke CI; Hu ZB; Xu J
    Curr Pharm Des; 2015; 21(12):1598-605. PubMed ID: 25594410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polylactide-poly(ethylene glycol) micellar-like particles as potential drug carriers: production, colloidal properties and biological performance.
    Stolnik S; Heald CR; Neal J; Garnett MC; Davis SS; Illum L; Purkis SC; Barlow RJ; Gellert PR
    J Drug Target; 2001; 9(5):361-78. PubMed ID: 11770706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Jun; 30(16):3009-19. PubMed ID: 19250665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.